Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

SARS-CoV-2 within-host diversity and transmission

Lythgoe KA. et al, (2021), Science, 372, eabg0821 - eabg0821

New Approaches for the Treatment of Chagas Disease.

Pandey RP. et al, (2021), Current drug targets, 22, 835 - 841

Antimicrobial resistance diagnostic use accelerator - Behavioural determinants of point-of-care diagnostic uptake, and adherence to prescription

Horgan P. et al, (2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101, 85 - 86

Determining the global burden of antimicrobial resistance - The GRAM project

Moore C. et al, (2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101, 12 - 12

Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis

Browne AJ. et al, (2020), BMC Medicine, 18

Global antibiotic consumption: A modelling study

Browne A. et al, (2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101, 91 - 91

Impact of a package of diagnostic tools, clinical algorithm, and training and communication on outpatient acute fever case management in low- and middle-income countries: protocol for a randomized controlled trial.

Salami O. et al, (2020), Trials, 21

Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17

Wiens KE. et al, (2020), The Lancet Global Health, 8, e1038 - e1060

Within-host genomics of SARS-CoV-2

Lythgoe KA. et al, (2020)

Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients.

Scott JT. et al, (2020), EBioMedicine, 52

Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients

Scott JT. et al, (2020), EBioMedicine, 52, 102601 - 102601

Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017

Troeger CE. et al, (2020), The Lancet Infectious Diseases, 20, 37 - 59

Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017

Troeger CE. et al, (2020), The Lancet Infectious Diseases, 20, 60 - 79

A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks—results from the Lassa fever pilot

Sigfrid L. et al, (2019), BMC Medicine, 17

Epidemiology of paediatric gastrointestinal colonisation by extended spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-west Cambodia

van Aartsen JJ. et al, (2019), BMC Microbiology, 19

Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel

Saxena A. et al, (2019), BMC Medical Ethics, 20

Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data

Turner P. et al, (2019), BMC Medicine, 17

Surveillance and monitoring of antimicrobial resistance: limitations and lessons from the GRAM project

Schnall J. et al, (2019), BMC Medicine, 17

Improving the estimation of the global burden of antimicrobial resistant infections

Limmathurotsakul D. et al, (2019), The Lancet Infectious Diseases, 19, e392 - e398

Changes in antibiotic resistance in animals

Moore CE., (2019), Science, 365, 1251 - 1252

Load More

1
2
3
4
5
6

Include forthcoming?